Ketamine normalizes subgenual cingulate cortex hyper-activity in depression
Sign Up to like & getrecommendations! Published in 2020 at "Neuropsychopharmacology"
DOI: 10.1038/s41386-019-0591-5
Abstract: Mounting evidence supports the rapid antidepressant efficacy of the N -methyl- d -aspartate receptor antagonist, ketamine, for treating major depressive disorder (MDD); however, its neural mechanism of action remains poorly understood. Subgenual anterior cingulate cortex… read more here.
Keywords: patients mdd; sgacc hyper; ketamine; hyper activity ... See more keywords